← Back to Search
AHA Guidelines For Primary Prevention Of Cardiovascular Disease And Stroke: 2002 Update: Consensus Panel Guide To Comprehensive Risk Reduction For Adult Patients Without Coronary Or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory And Coordinating Committee.
T. A. Pearson, S. Blair, S. Daniels, R. Eckel, J. Fair, S. Fortmann, B. A. Franklin, L. Goldstein, P. Greenland, S. Grundy, Yuling Hong, N. Miller, R. Lauer, I. Ockene, R. Sacco, J. Sallis, S. Smith, N. Stone, K. Taubert
Published 2002 · Medicine
Download PDFAnalyze on Scholarcy
The initial Guide to the Primary Prevention of Cardiovascular Diseases was published in 1997 as an aid to healthcare professionals and their patients without established coronary artery disease or other atherosclerotic diseases.1 It was intended to complement the American Heart Association (AHA)/American College of Cardiology (ACC) Guidelines for Preventing Heart Attack and Death in Patients with Atherosclerotic Cardiovascular Disease (updated2) and to provide the healthcare professional with a comprehensive approach to patients across a wide spectrum of risk. The imperative to prevent the first episode of coronary disease or stroke or the development of aortic aneurysm and peripheral arterial disease remains as strong as ever because of the still-high rate of first events that are fatal or disabling or require expensive intensive medical care. The evidence that most cardiovascular disease is preventable continues to grow. Results of long-term prospective studies consistently identify persons with low levels of risk factors as having lifelong low levels of heart disease and stroke.3,4⇓ Moreover, these low levels of risk factors are related to healthy lifestyles. Data from the Nurses Health Study,5 for example, suggest that in women, maintaining a desirable body weight, eating a healthy diet, exercising regularly, not smoking, and consuming a moderate amount of alcohol could account for an 84% reduction in risk, yet only 3% of the women studied were in that category. Clearly, the majority of the causes of cardiovascular disease are known and modifiable. This 2002 update of the Guide acknowledges a number of advances in the field of primary prevention since 1997. Research continues to refine the recommendations on detection and management of established risk factors, including evidence against the safety and efficacy of interventions once thought promising (eg, antioxidant vitamins).6 This, in turn, has …
This paper references
PRIMARY PREVENTION OF CORONARY HEART DISEASE IN WOMEN THROUGH DIET AND LIFESTYLE
M Eir (2000)
Statement on exercise: benefits and recommendations for physical activity programs for all Americans. A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart Association.
G. Fletcher (1996)
Prediction of coronary heart disease using risk factor categories.
P. Wilson (1998)
25th Bethesda Conference: Future Personnel Needs for Cardiovascular Health Care. November 15-16, 1993.
Rolf M. Gunner (1994)
ACSM's Guidelines for Exercise Testing and Prescription
L. Pescatello (1995)
Obesity and heart disease: a statement for healthcare professionals from the Nutrition Committee, American Heart Association.
R. Eckel (1997)
Agency for Healthcare Policy and Research. Treating Tobacco Use and Dependence: US Department of Health and Human Services Public Health Services Report
The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI)
Prevention Conference V Beyond Secondary Prevention : Identifying the High-Risk Patient for Primary Prevention : Executive Summary
S. C. Smith (2000)
Optimal risk factors in the population: prognosis, prevalence, and secular trends; data from Göteborg population studies.
A. Rosengren (2001)
Guide to Preventive Cardiology for Women
L. Mosca (1999)
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association.
L. Goldstein (2001)
Compliance in Healthcare and Research
Editado por Lora E. Burke (2001)
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).
S. Grundy (2001)
Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.
Luigi Mosca (2001)
AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association.
R. Krauss (2000)
Md: National Institutes of Health, National Heart, Lung, and Blood Institute
update : a statement for healthcare professionals from the American Heart Association and the American College of Cardiology
The way I see it: House officers need formal career development
A. Connor (2002)
Guide to primary prevention of cardiovascular diseases. A statement for healthcare professionals from the Task Force on Risk Reduction. American Heart Association Science Advisory and Coordinating Committee.
S. Grundy (1997)
AHA dietary guidelines : revision
RM Krauss (1998)
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation
V. Fuster (2001)
Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women.
J. Stamler (1999)
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
C. Baigent (2002)
Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.
S. Grundy (1999)
Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology.
S. Grundy (1999)
Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the
L Mosca (2001)
AHA Science Advisory. Resistance exercise in individuals with and without cardiovascular disease: benefits, rationale, safety, and prescription: An advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association; Position paper endo
M. Pollock (2000)
Scientific Statements Ⅲ prevention Ⅲ risk factors Ⅲ cardiovascular disease Ⅲ stroke
Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Antithrombotic Trialists Collaboration
Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force.
N. Singh (2002)
Very-low fat diets.
D. Ornish (1999)
Vitamin E supplementation and cardiovascular events in high-risk patients.
S. Yusuf (2000)
Report of the expert committee on the diagnosis and classification of diabetes mellitus.
J. Gavin (2003)
Matching the Intensity of Risk Factor Management with the Hazard for Coronary Disease Events
Aspirin for the primary prevention of cardiovascular events: recommendations and rationale. US Preventive Services Task Force
Antioxidant Consumption and Risk of Coronary Heart Disease: Emphasis on Vitamin C, Vitamin E, and β-Carotene A Statement for Healthcare Professionals From the American Heart Association
D. Tribble (1999)
American Heart Association web site
AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology.
S. Smith (2001)
Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults.
F. Pi-Sunyer (1998)
Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S
M Hayden (2002)
[Alcohol and heart disease].
Y. Sugishita (1986)
Aspirin for the Primary Prevention of Cardiovascular Events: Recommendation and Rationale
U. P. S. T. Force (2002)
Resistance Exercise in Individuals With and Without Cardiovascular Disease
M. Pollock (2000)
Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators
S Yusuf (2000)
Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) full report: manuscript version. National Heart, Lung, and Blood Institute web site
AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology.
S. Smith (2001)
Aspirin for the primary prevention of cardiovascular events: recommendations and rationale.
U. P. S. T. Force (2002)
AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee.
T. A. Pearson (2002)
Statement on exercise. Benefits and recommendations for physical activity programs for all Americans. A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart association.
G. Fletcher (1992)
27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 8. Organization of preventive cardiology service.
T. Pearson (1996)
Standards of Medical Care for Patients With Diabetes Mellitus
Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 8. Organization of preventive cardiology
TA Pearson (1996)
Guide to Preventive Cardiology for Women.AHA/ACC Scientific Statement Consensus panel statement.
Luigi Mosca (1999)
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.
Treatment of Obesity in Adults (1998)
ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conference
V. Fuster (2001)
AHA Science Advisory. Antioxidant consumption and risk of coronary heart disease: emphasison vitamin C, vitamin E, and beta-carotene: A statement for healthcare professionals from the American Heart Association.
D. Tribble (1999)
Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations
S. Grundy (1999)
Get with the guidelines.
K. LaBresh (2000)
AHA Conference Proceedings. Prevention conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: executive summary. American Heart Association.
S. Smith (2000)
: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association
TA Pearson (2000)
This paper is referenced by
Physical Activity and Coronary Heart Disease It Is Never Too Late to Benefit
M. Sharratt (2004)
Exercise Training Reduces Neointimal Growth and Stabilizes Vascular Lesions Developing After Injury in Apolipoprotein E–Deficient Mice
Marianne Pynn (2004)
A public health action plan to prevent heart disease and stroke: the mandate for prevention across the continuum of care and across the lifespan.
E. Stuart-Shor (2004)
Protecting the heart: a practical review of the statin studies.
Ong Ht (2002)
ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Th
M. Patel (2009)
Changes in Residential Proximity to Road Traffic and the Risk of Death From Coronary Heart Disease
W. Gan (2010)
Insulin Resistance Syndrome
B. Fletcher (2004)
Non-Alcoholic Fatty Liver Disease: A 360-degree Overview
E. Bugianesi (2020)
Approach to the Treatement of Metabolic Syndrome
I. Aganović (2007)
Stellenwert von Kardio-CT und Kardio-MR zur Bestimmung des koronaren Risikos
F.E.S.C. Prof. Dr. med. S. Silber F.A.C.C. (2005)
Cardiovascular risk in first degree relatives of patients with premature coronary heart disease
R. K. Dhillon (2009)
Characterization, prevalence, and risk factors of spontaneous and experimental atherosclerosis and vascular imaging in psittaciformes
H. Beaufrère (2013)
[Lifestyles related with cardiovascular risk in university students].
Juana Yikenia Castro Cuesta (2014)
APOLIPOPROTEIN B GENE POLYMORPHISMS IN PATIENTS FROM SERBIA WITH ISCHEMIC CEREBROVASCULAR DISEASE
A. Stanković (2007)
Depression, Vascular Conditions and Chronicity
A. Seldenrijk (2013)
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patie
J. Anderson (2007)
Effect of Dietary Magnesium and Calcium on Reducing the Risk of Atherosclerosis in High-Fat Diet Fed Rats
Rubaba Karim (2018)
Does an Aspirin a day keep the doctor away? Acetylsalicylic acid for the primary prevention of cardiovascular disease
M. Bayliss (2010)
Exercise prescription: knowledge, practice and attitude among South African doctor
G. Roos (2014)
Asymptomatic peripheral arterial disease: is pharmacological prevention of cardiovascular risk cost-effective?
B. Sigvant (2011)
Cost-effectiveness evaluation of aspirin in primary prevention of myocardial infarction amongst males with average cardiovascular risk in Iran
Mohammadreza Amirsadri (2017)
Nicotine in Senescence and Atherosclerosis
A. Centner (2020)
U. Maschewsky-Schneider (2009)
Development of Stroke Systems Recommendations From the American Stroke Association's Task Force on the Recommendations for the Establishment of Stroke Systems of Care:
J. Adams (2007)
Asociación de antiagregantes, ¿cuándo y cómo?
Ramiro López Menchaca (2007)
Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
D. Lackland (2012)
Approaches to reducing cardiovascular disease risk and stress effects in underserved populations
D. Witt (2014)
Effect of lipid disorders on arteriosclerosis in renal transplant recipients
D. Pistolas (2014)
Alan R. Lifson (2010)
Exploring quality and outcomes of cardiovascular primary care in Catalonia.
Eva Frigola Capell (2014)
The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia.
B. Bunting (2008)
The effect of conventional v. à la carte menu on energy and macronutrient intake among hospitalized cardiology patients.
Camilla S Larsen (2007)See more